News
Weight-Loss Injection News in Canada
Recalls, generic approvals and price changes that affect Canadians on GLP-1 medication. Each item is dated and cites the Health Canada record it comes from.
Apotex Recalls One Lot of Generic Ozempic Pens Over Incorrect Dose Display
Health Canada says pens from lot 7000636A of Apo-Semaglutide may show and deliver 0.25 mg or 0.5 mg instead of 1 mg. How to check your pen and what to do.
Sandoz's Generic Ozempic Is Approved, but Still Not on Pharmacy Shelves
Health Canada issued Sandoz's Notice of Compliance on September 16. Both of its DINs still read Approved, not Marketed. Until that changes, there is no Sandoz price to report.
Content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before starting any medication. GLP-1 medications require a valid prescription from a licensed Canadian physician.